Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.

Gene - 30 Dec 2018

Patil Vikas, Mahalingam Kulandaivelu

Abstract excerpt

BACKGROUND: Glioma is a wide category of brain tumor originates from glial cells. Lower-Grade Glioma (LGG) consists of World Health Organization (WHO) grade II and grade III gliomas. Since the LGGs can infiltrate into adjacent areas, the complete removal of tumor is difficult and it results in recurrence and malignant progression to high grade glioma. Our study uncovers robust survival indicators in LGG which can...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Checkpoint Kinase 2
Share to Glioma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isocitrate Dehydrogenase

Share to Neoplasm Grading

Share to Nuclear Proteins

Share to Paxillin

Share to Survival Analysis

Source

Identifiers

PMID: 30077762
DOI: 10.1016/j.gene.2018.08.001

Genes

MSH6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.PMID 30077762Read ↗

Identification of potential biomarkers related to glioma survival by gene expression profile analysisSemantic proximity Read ↗

A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade GliomaSemantic proximity Read ↗

Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade gliomaSemantic proximity Read ↗

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade GliomasSemantic proximity Read ↗

Comprehensive Characterization of a Novel E3-Related Gene Signature With Implications in Prognosis and Immunotherapy of Low-Grade GliomasSemantic proximity Read ↗

A multi-omics analysis-based model to predict the prognosis of low-grade gliomas.Semantic proximity Read ↗

Identification of a Tumor Microenvironment-Related Eight-Gene Signature for Predicting Prognosis in Lower-Grade GliomasSemantic proximity Read ↗

The Development and Validation of a Novel 71-Gene Signature for Risk Stratification and Prognosis in Lower Grade GliomaSemantic proximity Read ↗

Classifying lower grade glioma cases according to whole genome gene expressionSemantic proximity Read ↗

A novel ARHGAP family gene signature for survival prediction in glioma patients.Semantic proximity Read ↗

LGG subtypes based on the activity changes of immunologic and hallmark gene sets in cancerSemantic proximity Read ↗

Next-Generation Grade and Survival Expression Biomarkers of Human Gliomas Based on Algorithmically Reconstructed Molecular Pathways.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.